Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
Meyer, A
FEBS Lett (2013) 587:136672
We only have one set of parents, and we need to take care of them, and this advice has really brought surprising results
Many people find that once they reach a consistent dose, side effects become mild or disappear entirely